Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

Background And Purpose: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year.

Methods: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020).

Results: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths.

Conclusions: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT.

Citing Articles

The Impact of COVID-19 on Admissions and In-hospital Mortality of Patients With Stroke in Korea: An Interrupted Time Series Analysis.

Chang Y, Hwang S, Bai H, Park S, Cho E, Kim D J Prev Med Public Health. 2024; 58(1):60-71.

PMID: 39638301 PMC: 11824646. DOI: 10.3961/jpmph.24.432.

International practice patterns and perspectives on endovascular therapy for the treatment of cerebral venous thrombosis.

Brakel B, Rebchuk A, Ospel J, Chen Y, Heran M, Goyal M Int J Stroke. 2024; 20(3):319-327.

PMID: 39569543 PMC: 11874609. DOI: 10.1177/17474930241304206.

Genetic Testing Among Breast Cancer Patients in the Eastern Region of Saudi Arabia: Single-Center Experience.

Ghareeb G, Nass Z, Abu-Grain S, Alnaji A, Almohanna H, Nasser H J Epidemiol Glob Health. 2024; 14(3):1351-1357.

PMID: 39256315 PMC: 11442735. DOI: 10.1007/s44197-024-00296-4.

Stroke in Asia.

Tan K, Pandian J, Liu L, Toyoda K, Leung T, Uchiyama S Cerebrovasc Dis Extra. 2024; 14(1):58-75.

PMID: 38657577 PMC: 11250668. DOI: 10.1159/000538928.

Reducing the global burden of cerebral venous thrombosis: An international research agenda.

Coutinho J, van de Munckhof A, Aguiar de Sousa D, Poli S, Aaron S, Arauz A Int J Stroke. 2024; 19(6):599-610.

PMID: 38494462 PMC: 11292977. DOI: 10.1177/17474930241242266.

References

Cavalcanti D, Raz E, Shapiro M, Dehkharghani S, Yaghi S, Lillemoe K . Cerebral Venous Thrombosis Associated with COVID-19. AJNR Am J Neuroradiol. 2020; 41(8):1370-1376. PMC: 7658892. DOI: 10.3174/ajnr.A6644. View

Baldini T, Asioli G, Romoli M, Carvalho Dias M, Schulte E, Hauer L . Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis. Eur J Neurol. 2021; 28(10):3478-3490. PMC: 8014715. DOI: 10.1111/ene.14727. View

Sanchez van Kammen M, Heldner M, Brodard J, Scutelnic A, Silvis S, Schroeder V . Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic. JAMA. 2021; 326(4):332-338. PMC: 8317004. DOI: 10.1001/jama.2021.9889. View

Coutinho J, Zuurbier S, Aramideh M, Stam J . The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke. 2012; 43(12):3375-7. DOI: 10.1161/STROKEAHA.112.671453. View

Al-Mufti F, Amuluru K, Sahni R, Bekelis K, Karimi R, Ogulnick J . Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study. AJNR Am J Neuroradiol. 2021; 42(7):1196-1200. PMC: 8324265. DOI: 10.3174/ajnr.A7134. View

Ma A, Kase C, Shoamanesh A, Abdalkader M, Pikula A, Sathya A . Stroke and Thromboprophylaxis in the Era of COVID-19. J Stroke Cerebrovasc Dis. 2020; 30(1):105392. PMC: 7546195. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105392. View

Taquet M, Husain M, Geddes J, Luciano S, Harrison P . Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases. EClinicalMedicine. 2021; 39:101061. PMC: 8324974. DOI: 10.1016/j.eclinm.2021.101061. View

Roushdy T, Aref H, Kesraoui S, Temgoua M, Nono K, Gebrewold M . Stroke services in Africa: What is there and what is needed. Int J Stroke. 2022; 17(9):972-982. DOI: 10.1177/17474930211066416. View

Raymaekers V, Demeestere J, Bellante F, De Blauwe S, De Raedt S, Dusart A . The impact of COVID-19 on acute stroke care in Belgium. Acta Neurol Belg. 2021; 121(5):1251-1258. PMC: 8214455. DOI: 10.1007/s13760-021-01726-x. View

10.

Rana A, Nguyen T, Siegler J . Stroke and neurointervention in the COVID-19 pandemic: a narrative review. Expert Rev Med Devices. 2021; 18(6):523-531. DOI: 10.1080/17434440.2021.1928495. View

11.

Nwajei F, Anand P, Abdalkader M, Andreu Arasa V, Aparicio H, Behbahani S . Cerebral Venous Sinus Thromboses in Patients with SARS-CoV-2 Infection: Three Cases and a Review of the Literature. J Stroke Cerebrovasc Dis. 2020; 29(12):105412. PMC: 7571902. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105412. View

12.

Seiffert M, Brunner F, Remmel M, Thomalla G, Marschall U, LHoest H . Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims. Clin Res Cardiol. 2020; 109(12):1540-1548. PMC: 7402080. DOI: 10.1007/s00392-020-01723-9. View

13.

Siegler J, Cardona P, Arenillas J, Talavera B, Guillen A, Chavarria-Miranda A . Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry. Int J Stroke. 2020; 16(4):437-447. PMC: 7533468. DOI: 10.1177/1747493020959216. View

14.

Nguyen T, Abdalkader M, Nagel S, Qureshi M, Ribo M, Caparros F . Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion. JAMA Neurol. 2021; 79(1):22-31. PMC: 8576630. DOI: 10.1001/jamaneurol.2021.4082. View

15.

Siegler J, Abdalkader M, Michel P, Nguyen T . Therapeutic Trends of Cerebrovascular Disease during the COVID-19 Pandemic and Future Perspectives. J Stroke. 2022; 24(2):179-188. PMC: 9194541. DOI: 10.5853/jos.2022.00843. View

16.

Nogueira R, Abdalkader M, Qureshi M, Frankel M, Mansour O, Yamagami H . Global impact of COVID-19 on stroke care. Int J Stroke. 2021; 16(5):573-584. PMC: 8010375. DOI: 10.1177/1747493021991652. View

17.

Sanchez van Kammen M, Aguiar de Sousa D, Poli S, Cordonnier C, Heldner M, van de Munckhof A . Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. JAMA Neurol. 2021; 78(11):1314-1323. PMC: 8479648. DOI: 10.1001/jamaneurol.2021.3619. View

18.

Perry R, Tamborska A, Singh B, Craven B, Marigold R, Arthur-Farraj P . Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet. 2021; 398(10306):1147-1156. PMC: 8346241. DOI: 10.1016/S0140-6736(21)01608-1. View

19.

Alimohammadi A, Kim D, Field T . Updates in Cerebral Venous Thrombosis. Curr Cardiol Rep. 2022; 24(1):43-50. PMC: 8757924. DOI: 10.1007/s11886-021-01622-z. View

20.

Nguyen T, Haussen D, Qureshi M, Yamagami H, Fujinaka T, Mansour O . Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic. Stroke Vasc Neurol. 2021; 6(4):542-552. PMC: 8006491. DOI: 10.1136/svn-2020-000695. View